Children with epidermolysis bullosa (EB) who accept their condition and emotionally detach themselves from it tend to have a…
Articles by Joana Carvalho, PhD
When injected into the bloodstream, mesenchymal stem cells (MSCs) — cells that can grow into different cell types…
Scientists have identified two new variants in the COL7A1 gene associated with recessive dystrophic epidermolysis bullosa (RDEB) in…
When applied directly over skin wounds, the antibiotic gentamicin can restore the production of laminin 332 and promote…
SkinGun, a device designed to gently spray stem cells onto the skin of severe burn victims,…
All healthy volunteers participating in InMed Pharmaceuticals’ Phase 1 trial of INM-755, an investigational cannabinol cream for…
People with epidermolysis bullosa (EB) often use topical skin care products and need to be aware that products containing…
Krystal Biotech is opening its second gene therapy facility, called Astra, to support the production and potential commercialization of…
Abeona Therapeutics has begun its Phase 3 VIITAL trial evaluating EB-101, a gene-corrected cell therapy…
After its recent clinical hold by regulators, the Phase 3 VIITAL trial has been given the green light to…
The U.S. Food and Drug Administration (FDA) has refused to approve the initiation of…
RegeneRx Biopharmaceuticals announced the first patient enrolled in a Phase 2 clinical trial of RGN-137, the company’s investigational…